unc bpc 157 UPB BPC-157 5MG BPC-157

Regulatory note: The FDA added injectable GHK-Cu to a high-risk compounded substance list in September 2023

For patients with pernicious anemia, severe malabsorption, or acute neurological symptoms, injections remain the appropriate clinical choice

Advanced compound for enzymatic (NNMT) and metabolic pathway research

Complex drug approvals processes and other regulations arent meant to keep people from being proactive about their health

The Wegovy pill has been approved for long-term weight loss

Sergey Terushkin, MD, FACS Florida Surgery & Weight Loss Center is a physician-led medical weight loss, peptide therapy, bariatric care, and wellness practice serving patients throughout Florida through telehealth when clinically appropriate